Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        Altera
        Empower
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        Renasight
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Order Forms
        
        Signatera
        Signatera Publications
        Altera
        Empower
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        Prospera
        Renasight
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        Natera Academy Provider Education Hub
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Spectrum
Pericentric inversion (Inv) 9 variant - reproductive risk factor or benign finding?

Pericentric inversion (Inv) 9 variant - reproductive risk factor or benign finding?

Merrion K, Maisenbacher M. Journal of Assisted Reproduction and Genetics

Previous Resource

Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24-chromosome single-nucleotide polymorphism

Simon AL, Kiehl M, Fischer E, et al. Fertil Steril
Next Resource

Maternal body mass index is not associated with increased rates of maternal embryonic aneuploidy

Hughes L, McQueen D, Jungheim E, et al. Fertility and Sterility

Related Content

Compassionate Care Application - Spanish

Read More
Natera Product Brochure

Read More
Letter to the Editor by Megan Hall in response to Munne S.

Saucier J, Merrion K, Mash J, et al. Current Genomics 2013

Read More
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol

Johnson DS, Gemelos G, Baner J, et al. Hum Reprod

Read More
Origins and rates of aneuploidy in human blastomeres

Rabinowitz M, Ryan A, Gemelos G, et al. Fertil Steril

Read More
Comprehensive analysis of karyotypic mosaicism between trophectoderm and inner cell mass

ohnson DS, Cinnioglu C, Ross R, et al. Mol Hum Reprod

Read More
Evidence of selection against complex mitotic-origin aneuploidy during preimplantation development

McCoy RC, Demko ZP, Ryan A, et al. PLOS Genet

Read More
Common variants spanning PLK4 are associated with mitotic-origin aneuploidy in human embryos

McCoy RC, Demko ZP, Ryan A, et al. Science

Read More
Pregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocati

Idowu D, Merrion K, Wemmer N, et al. Fertil Steril

Read More
Whole genome prediction for preimplantation genetic diagnosis

Kumar A, Ryan A, Kitzman JO, et al. Genome Med

Read More
Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based

Demko ZP, Simon AL, McCoy RC, et al. Fertil Steril

Read More
Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24-chromosome single-nucleotide polymorphism

Simon AL, Kiehl M, Fischer E, et al. Fertil Steril

Read More
Maternal body mass index is not associated with increased rates of maternal embryonic aneuploidy

Hughes L, McQueen D, Jungheim E, et al. Fertility and Sterility

Read More
Relationship between paternal factors and embryonic aneuploidy of paternal origin

Bonus ML, McQueen DB, Ruderman R, et al. Fertility and Sterility

Read More
HIPAA Authorization to Release Records to a Partner/Significant-other

Read More
Compassionate Care Application

Read More
almost 2 years ago
A Genetic Counselor Helps a Couple Navigate Growing a Family

Read Article
over 1 year ago
Navigating the IVF Journey

Read Article
What is PGT-A? And How Does It Support IVF?

Read Article
over 2 years ago
Corrine’s story: Horizon catches carrier mutation missed by standard screen

Watch Video

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.